Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2

Cancer Research

Volumn 61, Issue 24, 2001, Pages 8730-8736

  Bello, Lorenzo ^a,b   Giussani, Carlo ^a   Pluderi, Mauro ^a   Tomei, Giustino ^a   Villani, Roberto M ^a   Nikas, Demetrios ^b   Carroll, Rona S ^b   Machluf, Marcelle ^b   Zhang, Jianping ^b   Black, Peter M ^b   Lucini, Valeria ^a   Carrabba, Giorgio ^a   Bikfalvi, Andreas ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; GELATINASE A; INTEGRIN; PROTEIN PEX; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ADULT; AGED; ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CULTURE MEDIA; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLIOMA; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; RECEPTORS, VITRONECTIN; VITRONECTIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035893737     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Halting angiogenesis suppresses carcinoma cell invasion
2. Role of integrins in angiogenesis
3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
4. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
5. Brain tumor cell invasion, anatomical and biological considerations
6. Requirement of vascular integrin ανβ3 for angiogenesis
7. Definition of two angiogenic pathways by distinct αν integrins
8. Integrin ανβ 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
9. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinase and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors
10. ανβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF
11. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the ανβ3 integrin, osteopontin and thrombin
12. Malignant astrocytomas
13. Tumor cell invasion and angiogenesis in the central nervous system
14. Glioma invasion in the central nervous system
15. High levels of gelatinase-B and gelatinase-A in metastatic glioblastoma
16. Gelatinase A (MMP-2), gelatinase B (MMP-9) and membrane type matrix metalloproteinase-I (MTI-MMP) are involved in different aspects of the pathophysiology of malignant glioma
17. Glioma invasion in vitro: Regulation by matrix metalloproteinase-2 and protein kinase C
18. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin ανβ 3
19. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
20. Anti-integrin ανβ3 blocks human breast cancer growth and angiogenesis in human skin
21. Different signal transduction properties of KDR and fit-I, two receptors for VEGF
22. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin and von Willebrand factor
23. Expression of cyclo-oxygenase 2 (COX 2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398
24. Hypoxia induces differential expression of the integrin receptors ανβ3 and ανβ5 in cultured human endothelial cells
25. Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis
26. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOHterminal hemopexin-like domain of human gelatinase A
27. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine upregulation of vascular endothelial growth factor expression
28. Matrix metalloproteinase-2 activation modulates glioma cell migration
29. Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves αν and β1 integrins
30. ανβ3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor in cultured endothelial cells
31. Microvessel density is a prognostic indicator for patients with astroglial brain tumors
32. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
33. Angiostatin suppress glioma growth in vivo
34. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
35. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
36. Suppression of angiogenesis by lentiviral delivery of PEX, a non catalytic fragment of matrix metalloproteinase 2
37. Endogenous angiogenesis inhibitors and their therapeutic implications
38. Serum endostatin levels are elevated in patients with soft tissue sarcomas
39. Antibodies to endostatin in a multifocal glioblastoma patient
40. Increased Fas ligand expression in the tumor tissue and serum of patients with testicular germ cell tumors with seminomatous elements